Utility of Novel Echocardiographic Measurements To Improve Prenatal Diagnosis of Coarctation of The Aorta

Download as pdf or txt
Download as pdf or txt
You are on page 1of 7

www.nature.

com/scientificreports

OPEN Utility of novel echocardiographic


measurements to improve
prenatal diagnosis of coarctation
of the aorta
Takuya Fujisaki 1, Yoichiro Ishii 1*, Kunihiko Takahashi 1, Masayoshi Mori 1, Kumiyo Matsuo 1,
Dai Asada 1, Hisaaki Aoki 1, Sanae Tsumura 2, Shigemitsu Iwai 2 & Futoshi Kayatani 1
Prenatal recognition of coarctation of the aorta (CoA) may improve neonatal survival and reduce
morbidity. However, prenatal diagnosis of CoA remains challenging, with relatively high false-
positive and false-negative rates. This study aimed to identify a novel formula based on fetal
echocardiographic measures to predict prenatal identification of CoA. A retrospective comparison on
the echocardiographic evaluation of 30 patients with suspected CoA between May 2016 and April 2021
was performed. The patients were divided into a postnatal surgical intervention group (n = 13) and a
non-intervention group (n = 17). The measurements that showed significant differences were aortic
isthmus diameter Z-score (p < 0.001), ductus arteriosus diameter/aortic isthmus diameter (p < 0.001),
and distal aortic arch (DA) index (p < 0.001). In the receiver operating characteristic curves analysis,
the DA index was the largest with an area under the curve of 0.941 and a cutoff value of 1.28, with a
sensitivity of 85% and a specificity of 94%. Measurement of the DA index improved the diagnostic rate
of fetal CoA and a DA index ≧ 1.28 indicated fetal CoA cases requiring surgical intervention.

Coarctation of the aorta (CoA) is one of the most common congenital heart defects in the pediatric population,
accounting for 4–8% of all infants with congenital heart d ­ efects1,2. CoA is defined as a discrete narrowing of the
aorta in the region of the ligamentum arteriosum and distal portion to the origin of the left subclavian artery,
although more diffuse forms of the disease may involve the arch or isthmus to varying d ­ egrees3. If CoA is not
diagnosed at the prenatal stage or in the immediate neonatal period, aortic obstruction with distal hypoperfusion,
metabolic acidosis, renal injury, left ventricular (LV) dysfunction, pulmonary edema, and pulmonary hyperten-
sion may ­occur4,5. Prenatal detection of CoA remains a challenge despite its importance, which is indicated by
the significantly higher mortality and morbidity in newborns without prenatal d ­ etection4,6–8. Several studies
have described how detect CoA prenatally, but all have multiple measurement sites and complicated formulas.
In addition, false-positive and false-negative rates are reportedly ­high9. Recently, the ratio of the aortic arch
diameter at the left subclavian artery to the distance between the left carotid artery and the left subclavian artery
has been described as being significantly longer in neonates and infants with C ­ oA10. Therefore, we considered
the possibility of applying this test to the diagnosis of CoA during the fetal period. We aimed to investigate a
new criterion to improve the diagnostic rate of aortic constriction during the fetal period.

Methods
Patients and methods. All the patients provided written informed consent. All the procedures were per-
formed in accordance with the principles of the Declaration of Helsinki. The study protocol was approved by
the Institutional Ethics Review Board of Osaka Women’s and Children’s Hospital (No. 1354). This retrospective
review assessed 30 patients with suspected CoA between May 2016 and April 2021 at the Osaka Women’s and
Children’s Hospital. We excluded cases with complicated congenital heart diseases such as single ventricular
disease and transposition of great arteries. CoA was diagnosed during pregnancy at approximately 30 weeks of
gestation. Maternal, prenatal, and postnatal medical records, including cardiac surgery reports, were reviewed
for gestational age, chromosomal abnormalities, echocardiographic findings, and fetal/neonatal clinical courses.
Echocardiographic studies were performed using the GE Voluson E10 equipment. A total of 10 cardiovascu-

1
Department of Pediatric Cardiology, Osaka Women’s and Children’s Hospital, 840 Murodo‑Cho, Izumi,
Osaka 594‑1101, Japan. 2Department of Cardiovascular Surgery, Osaka Women’s and Children’s Hospital, Osaka,
Japan. *email: [email protected]

Scientific Reports | (2023) 13:4912 | https://doi.org/10.1038/s41598-023-31749-8 1

Vol.:(0123456789)
www.nature.com/scientificreports/

lar dimensions were calculated from fetal studies around 30 weeks of gestation. General heart measurements
included cardiothoracic area ratio and total cardiac dimension. Right heart measurements included the right
ventricular (RV) end-diastolic dimension, tricuspid valve (TV) diameter, pulmonary valve (PV) diameter, main
pulmonary artery diameter, and ductus arteriosus diameter. Left heart measurements included the left ven-
tricular (LV) end-diastolic dimension, mitral valve (MV) diameter, aortic valve (AV) diameter, ascending aortic
(AAO) diameter, ductus arteriosus, and aortic isthmus diameter. Ratios of the RV end-diastolic dimension to LV
end-diastolic dimension (RV/LV), PV diameter to AV diameter, TV diameter to MV diameter, ductus arteriosus
to aortic isthmus diameter (D/I), and the distal aortic arch (DA) index in the prenatal period have been calcu-
lated, and have been indicated as simple and noninvasive parameters to detect CoA in neonates and ­infants10. In
this study, the DA index, which was calculated as the ratio of the distance between the left carotid artery and the
left subclavian artery, was used to screen for patients with CoA (Fig. 1).
According to the clinical course after birth, patients were divided into two groups: the postnatal surgical
intervention group (group S), and the non-intervention group (group N). Prostaglandin E1 continuous infu-
sion after birth was administered based on the last two prenatal assessments and following the initial postanal
echocardiogram. Confirmation of definitive CoA and decision to perform neonatal surgical repair were made
based on clinical features of progressive heart failure and/or echocardiographic features of flow acceleration
or loss of pulsatility at the site of the aortic isthmus. In addition, surgical repair was decided based on contrast
computed tomography findings, including narrow isthmus morphology with a posterior shelf and/or hypoplas-
tic arch morphology. If CoA was suspected based on echocardiographic estimation, the aortic arch was closely
observed until ductal closure. All the clinical, echocardiographic, and operative data were reviewed. Follow-up
in the neonatal period was completed for all 30 patients. Fetal cardiac dimension measurements were compared
between the two groups.

Statistical analysis. Data are shown as numbers, millimeters, Z-score, range, and mean ± standard devia-
tion. Continuous and normally distributed data were analyzed using the Mann–Whitney U test. Categorical
variables were analyzed using Fisher’s exact test. The area under the curve (AUC) and 95% confidence interval of
the receiver operator characteristic (ROC) curve were computed using the predicted probability of the diagnosis
of CoA. All statistical analyses were performed using EZR (Saitama Medical Center, Jichi Medical University,
Saitama, Japan), a graphical user interface for R (The R Foundation for Statistical Computing, Vienna, Austria).
It is a modified version of the R commander designed to add statistical functions frequently used in biostatistics.
A p-value < 0.05 was considered to be statistically significant. All morphologic parameters and distance measure-
ments were made by two independent observers (T. F. and Y.I.), who were blinded to the final diagnosis. There
was no significant inter-observer variability in the echocardiographic measurements.

Results
Patient demographics. A total of 30 pregnant women and their fetuses (11 boys and 19 girls) underwent
echocardiographic examination due to suspicion of CoA and referral from obstetrics and needed postnatal man-
agement, and underwent surgical repair, if needed, based on postnatal diagnosis. A total of 13 patients required
surgical repair of the aortic isthmus portion (S group) and 17 patients did not need postnatal surgical repair
(group N). The patient characteristics are shown in Table 1. The mean gestational age based on the evaluated fetal
echocardiogram was 31.6 ± 2.0 weeks (range 28–35 weeks). The mean gestational age and body weight at birth
were 38.5 ± 2.4 weeks (range 32–41 weeks) and 2732 ± 598 g (range 1140–3566 g), respectively.

Clinical diagnosis and characteristics. For the patients in group S, the condition was identified by clini-
cal manifestation and observed findings including narrowing of the aorta and the presence of a posterior shelf

Figure 1.  Echocardiographic and enhanced computed tomography scheme of an aortic arch (DA index = d1/
d2). Echocardiographic and enhanced computed tomography image of a normal aortic arch with normal DA
index (a) and CoA with abnormal DA index (b). The DA index was the ratio of the distance between the origin
of the left carotid artery and the origin of the left subclavian artery (d1) to the diameter of the distal aortic arch
at the origin of the left subclavian artery (d2). DA distal aortic arch, CoA coarctation of the aorta.

Scientific Reports | (2023) 13:4912 | https://doi.org/10.1038/s41598-023-31749-8 2

Vol:.(1234567890)
www.nature.com/scientificreports/

Group S (n = 13) Group N (n = 17) p-value


GA at echocardiography (weeks) 31.4 ± 2.0 31.8 ± 2.0 0.702
GA at birth (weeks) 38.2 ± 2.1 38.6 ± 2.7 0.325
Birth weight (g) 2684 ± 561 2769 ± 639 0.592
Male, n (%) 5 (38%) 6(35%) 1
Ductal shock 0 0 –
Cardiac complication, n (%)
VSD 10 (77%) 4 (24%) 0.009*
PLSVC 3 (23%) 4 (24%) 1
BAV 3 (23%) 2 (12%) 0.628
Kabuki make-up syndrome Multiple abnormality syndrome
Heterotaxy syndrome 22q11.2 deletion syndrome
Other complications
Heterotaxy syndrome
Turner syndrome
Trisomy 21

Table 1.  Patient and clinical characteristics of each group patients (n = 30). GA gestational age, VSD
ventricular septal defect, PLSVC persistent left superior vena cava,; BAV bicuspid aortic valve. *p < 0.05
between group S and group N.

in the wall of the aorta, as well as other abnormal findings by Doppler imaging. There were no significant dif-
ferences between the two groups in terms of the examination week, birth week, birth weight, or sex. Regarding
intracardiac complications, 14 had ventricular septal defects (VSD) (46.7%), 7 had persistent left superior vena
cava (PLSVC) (23.3%), and 5 had bicuspid aortic valve (BAV) (16.7%). There were significant differences in the
presence of VSD, but no significant differences between PLSVC and BAV. In addition, genetic or chromosomal
syndrome was diagnosed in seven neonates (23.3%), including 22q11.2 deletion syndrome, multiple malforma-
tion syndrome (auricle, external genitalia, and cardiac anomaly), Kabuki make-up syndrome, Turner syndrome,
trisomy 21, or heterotaxy syndrome. There were no significant differences in the presence or absence of these
syndromes. All patients were alive during this investigation and were followed-up after birth.

Analysis of fetal echocardiographic parameters. Table 2 presents the Z-score of the fetal cardiac
dimensions divided by the patient group. No significant differences were observed among the groups except
for the Z-score of the aortic isthmus (p < 0.01). Table 3 and Fig. 2 present the ratios of the cardiac parameters
for each group. The D/I ratio and DA index were significantly different between groups S and N (p < 0.001 and
p < 0.0001, respectively). The inter-observer variability is shown in Supplementary Fig. S1.

Analysis of ROC curve. The ROC curves for the three parameters with significant differences are presented
in Fig. 3. The AUC for the DA index was found to be greater than that for the other two parameters. The DA
index had a sensitivity of 85% and specificity of 94% with a cutoff value of 1.28.

Follow‑up. All 13 patients in group S received postnatal PGE1 and underwent initial surgery on postnatal
day 14.0 ± 10.9. Arch repair was performed with/without VSD closure in 11 patients and bilateral pulmonary
artery banding in two patients. Only one patient with suspected CoA received PGE1 infusion immediately after

Group S (n = 13) Group N (n = 17) p-value


RVEDD 0.5 ± 1.2 0 ± 1.7 0.263
TVD 0.6 ± 1.6 0.9 ± 1.5 0.509
PVD 1.3 ± 1.6 1.0 ± 1.6 0.834
MPA 1.6 ± 1.3 1.5 ± 1.6 0.773
LVEDD − 1.6 ± 1.0 − 1.3 ± 1.2 0.709
MVD − 1.1 ± 1.8 − 0.9 ± 1.9 0.77
AVD − 1.5 ± 2.3 − 0.9 ± 1.8 0.408
AAO − 1.1 ± 1.5 − 1.3 ± 1.0 0.615
Ductus arteriosus 2.8 ± 2.3 2.8 ± 2.0 0.95
Isthmus − 3.6 ± 1.0 − 1.3 ± 1.8 < 0.01*

Table 2.  Fetal echocardiographic dimensions Z-score compared between groups. RVEDD right ventricular
end-diastolic diameter, LVEDD left ventricular end-diastolic diameter, TVD tricuspid valve diameter, MVD
mitral valve diameter, MPA main pulmonary artery, AAO ascending aorta, PVD pulmonary valve diameter,
AVD aortic valve diameter, DA index distal aortic arch index. *p < 0.05 between group S and group N.

Scientific Reports | (2023) 13:4912 | https://doi.org/10.1038/s41598-023-31749-8 3

Vol.:(0123456789)
www.nature.com/scientificreports/

Group S (n = 13) Group N (n = 17) p-value


RVEDD/LVEDD 1.5 ± 0.4 1.3 ± 0.4 0.183
TVD/MVD 1.5 ± 0.5 1.5 ± 0.3 0.818
MPA/AAO 1.6 ± 0.2 1.6 ± 0.3 0.869
PVD/AVD 1.8 ± 0.4 1.5 ± 0.3 0.187
Ductus/isthmus 2.0 ± 0.4 1.5 ± 0.4 < 0.001*
DA index 1.6 ± 0.4 0.8 ± 0.3 < 0.0001*

Table 3.  Ratio of cardiac parameters and multiplier compared between groups. RVEDD right ventricular end-
diastolic diameter, LVEDD left ventricular end-diastolic diameter, TVD tricuspid valve diameter, MVD mitral
valve diameter, MPA main pulmonary artery, AAO ascending aorta, PVD pulmonary valve diameter, AVD
aortic valve diameter, DA index distal aortic arch index. *p < 0.05 between group S and group N.

Figure 2.  Ratio of cardiac parameter. Box-and-whisker diagram comparing different ratios of cardiac
parameters. RVEDD right ventricle end-diastolic diameter, LV left ventricle end-diastolic diameter, TVD
tricuspid valve diameter, MVD mitral valve diameter, MPA main pulmonary artery, AAO ascending aorta, PV
pulmonary valve, AV aortic valve, DA distal aortic arch index, ns not significant.

Figure 3.  ROCs of three parameters with significant differences. ROC using the DA index had a sensitivity of
85% and specificity of 94% (AUC = 0.941). The optimal and most effective cutoff value is 1.28 when using the
DA index to predict coarctation of the aorta fetuses. ROC receiver operating characteristic curves, DA distal
aortic arch, AUC​area under the curve.

Scientific Reports | (2023) 13:4912 | https://doi.org/10.1038/s41598-023-31749-8 4

Vol:.(1234567890)
www.nature.com/scientificreports/

birth. After stopping PGE1 infusion, patent ductus arteriosus closure was observed without circulatory collapse
or need for surgical repair. The 17 patients in group N had an almost normal aorta confirmed by transthoracic
echocardiography performed after the ductus arteriosus closed during a 12-month follow-up with no clinical
evidence of aortic obstruction. Postnatal echocardiographic measurements showed that the DA index value was
significantly higher in group S (1.5 ± 0.6 vs. 0.8 ± 0.2, p < 0.0001) and the cutoff value was 1.25 on the ROC curve
(Table 4, Fig. 4).

Discussion
Multiparametric diagnostic models integrating different ultrasound signs for the detection of CoA in the fetal
period were reported in only four studies. Arya et al.11 reported the best combination of sensitivity and specificity
with a predictive model integrating the angle between the ascending aorta and descending aorta, and between the
transverse aorta and descending aorta. Mărginean et al.12 reported a combination of RV/LV < 1.5, AoI < 4.2 mm,
and AD/AoI > 1.4 gave the overall best predictive accuracy for CoA, although the false-positive rate was 13% and
false-negative rate was 44%. Thus, in past reports, multiple measurement sites and formulas have been proposed,
and the false-positive and false-negative rates are high.
In the neonatal period and in childhood, Ali et al.10 reported that the DA diameter/distance between the
second and third branches of the aortic arch was smaller (less than 1.5) in cases of CoA. When we applied this
report to our research, we thought that it would be useful because both the false positive and false negative rates
were lower than those reported in other studies.
Various developmental aberrations have been proposed as possible explanations for aortic arch abnormalities.
Morphological abnormalities proposed as an explanation for CoA concern the fetal blood flow and hemodynamic
theory. A reduction in the volume of blood passing through the ascending aorta during the fetal period in CoA,
particularly with VSD, that may affect the timing of surgical repair timing, LV outflow obstruction, and tubular
hypoplasia of the transverse arch, postnatally leads to the development of CoA. In contrast, S­ koda13 speculated
that the constriction of the aorta is related to closure of the ductus arteriosus extending into the walls of the aorta,
a proposal that is referred to as the Skodiac hypothesis or Ductus tissue theory. Yokoyama et al.14 determined that
mature-phenotype smooth muscle cells in the ductus arteriosus participate in the immediate closure of the ductus
arteriosus after birth. The extension of ductus tissue into the aortic wall was followed and led to observations
of the CoA phenotype. The molecular mechanism of development of CoA is thought to involve the differential
expression of the myosin heavy chain isoforms SM1 and SM2, markers for differentiated smooth muscle cells,
which were lower in the intima of the coarctation segments than in that of the ductus arteriosus. These data
suggest that smooth cell differentiation is involved in the narrowing aortic isthmus following ductus closure.
Meanwhile, during development of the fetal aortic arch, the left seventh intersegmental artery of the dorsal
aorta shortens to form the left subclavian artery after birth. We hypothesized that in addition to the thinning

Group S (n = 13) Group N (n = 17) p-value


DA Index 1.5 ± 0.6 0.8 ± 0.2 < 0.0001*

Table 4.  DA index after birth compared between groups. DA index distal aortic arch index. *p < 0.05 between
group S and group N.

Figure 4.  Ratio of cardiac parameter and ROC curve of DA index after birth. (a) Box-and-whisker diagram
comparing each ratio of DA index after birth. (b) ROC of DA index after birth. ROC receiver operator
characteristic curves, DA distal aortic arch.

Scientific Reports | (2023) 13:4912 | https://doi.org/10.1038/s41598-023-31749-8 5

Vol.:(0123456789)
www.nature.com/scientificreports/

of the distal aortic arch due to decreased blood flow in the ascending aorta, as described in the hemodynamic
theory, the left seventh intersegmental artery shortens over a very long distance, and any malfunction during
this time would cause the distance between the second and third branches of the aortic arch to become longer.
As a result, we speculate that focusing on the second-third branch distance and measuring the DA index will
increase the extraction rate of potential patients with CoA.
Our results showed that the DA index is useful for screening neonatal patients to determine whether surgical
intervention is needed. A DA index ≧1.28 was useful for detecting CoA in terms of both sensitivity and specificity
compared to previous reports. In addition, we examined the DA index using postnatal echocardiography and
confirmed that there were significant differences between the two groups, as in previous reports.
To prevent severe postnatal respiratory and circulatory failure, detailed scanning of the fetal heart is critical
when a cardiac disproportion is noted, or when cardiac structures are not visualized on routine echocardio-
graphic scanning. The early recognition of CoA reduces morbidity and ­mortality15,16. As advances in diagnostic
and surgical techniques have evolved, early- to mid-term outcomes for patients with CoA are excellent.
This study has several limitations. First, the study design was retrospective with a small number of patients
and thus had all the limitations inherent to such a design. Future large multicenter studies sharing the same
imaging protocols are needed to develop objective models for risk assessment in fetal patients and to ascertain
the actual diagnostic performance of prenatal echocardiography in detecting this anomaly. Secondly, despite
innovations in fetal imaging technology, it is possible to visualize the neck vessels of almost all fetuses; in some
cases, the difficulty of obtaining this view may be influenced by the position of the fetus and by the obesity of
the mother. In these cases, reassessment was needed with re-examination.
In conclusion, the prenatal detection rate of CoA may be improved when the DA index is used. The imple-
mentation of this assessment may prevent neonates from experiencing circulatory shock.

Data availability
The datasets generated and/or analyzed during the current study are available from the corresponding author
upon reasonable request.

Received: 1 August 2022; Accepted: 16 March 2023

References
1. Rosenthal, E. Coarctation of the aorta from fetus to adult: Curable condition or lifelong disease process? Heart 91, 1495–1502
(2005).
2. Bjornard, K., Riehle-Colarusso, T., Gilboa, S. M. & Correa, A. Patterns in the prevalence of congenital heart defects, Metropolitan
Atlanta, 1978 to 2005. Birth. Defects Res. A Clin. Mol. Teratol. 97, 87–94 (2013).
3. Reifenstein, G. H., Levine, S. A. & Gross, R. E. Coarctation of the aorta; a review of 104 autopsied cases of the adult type, 2 years
of age or older. Am. Heart J. 33, 146–168 (1947).
4. Jowett, V. et al. Sonographic predictors of surgery in fetal coarctation of the aorta. Ultrasound Obstet. Gynecol. 40, 47–54 (2012).
5. Schneider, C. et al. Development of Z-scores for fetal cardiac dimensions from echocardiography. Ultrasound Obstet. Gynecol. 26,
599–605 (2005).
6. Franklin, O. et al. Prenatal diagnosis of coarctation of the aorta improves survival and reduces morbidity. Heart 87, 67–69 (2002).
7. Brown, K. L. et al. Delayed diagnosis of congenital heart disease worsens preoperative condition and outcome of surgery in neo-
nates. Heart 92, 1298–1302 (2006).
8. Sivanandam, A., Nyholm, J., Wey, A. & Bass, J. L. Right ventricular enlargement in utero: Is it coarctation? Pediatr. Cardiol. 36,
1168–1177 (2015).
9. Familiari, A. et al. Risk factors for coarctation of the aorta on prenatal ultrasound: A systematic review and meta-analysis. Circula-
tion 135, 772–785 (2017).
10. Dodge-Khatami, A., Ott, S., Di Bernardo, S. & Berger, F. Carotid-subclavian artery index: New echocardiographic index to detect
coarctation in neonates and infants. Ann. Thorac. Surg. 80, 1652–1658 (2005).
11. Arya, B., Bhat, A., Vernon, M., Conwell, J. & Lewin, M. Utility of novel fetal echocardiographic morphometric measures of the
aortic arch in the diagnosis of neonatal coarctation of the aorta. Prenat. Diagn. 36, 127–134 (2016).
12. Mărginean, C. et al. The role of ventricular disproportion, aortic, and ductal isthmus ultrasound measurements for the diagnosis
of fetal aortic coarctation, in the third trimester of pregnancy. Med. Ultrason. 17, 475–481 (2015).
13. Skoda, J. Protokoll der Sektions-Sitzung fur Physiologie und Pathologie, am 19. okt. Z kaiserlichkoniglichen Gesellschft der Aerzte zu
Wien 710–722 (1855).
14. Utako, Y., Yasuhiro, I., Susumu, M. & Yoshihiro, I. Pathology and molecular mechanisms of coarctation of the aorta and its associa-
tion with the ductus arteriosus. J. Physiol. Sci. 67, 259–270 (2017).
15. Punukolla, M., Harnden, A. & Tulloh, R. Coarctation of the aorta in the newborn. BMJ 343, 1–5 (2011).
16. Nihoyannopoulos, P., Karas, S., Sapsford, R. N., Hallidie-Smith, K. & Foale, R. Accuracy of two-dimensional echocardiography in
the diagnosis of aortic arch obstruction. JACC​10, 1072–1077 (1987).

Acknowledgements
The authors thank the illustrator Manami Orii who provided a wonderful illustration (Fig. 1).

Author contributions
All the authors participated in the research design. T.F. and Y.I. performed data management and statistical
analyses after discussions with the other authors. All authors participated in data interpretation and writing of
the manuscript. All authors have taken responsibility for the decision to submit the manuscript for publication.

Competing interests
The authors declare no competing interests.

Scientific Reports | (2023) 13:4912 | https://doi.org/10.1038/s41598-023-31749-8 6

Vol:.(1234567890)
www.nature.com/scientificreports/

Additional information
Supplementary Information The online version contains supplementary material available at https://​doi.​org/​
10.​1038/​s41598-​023-​31749-8.
Correspondence and requests for materials should be addressed to Y.I.
Reprints and permissions information is available at www.nature.com/reprints.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and
institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the
Creative Commons licence, and indicate if changes were made. The images or other third party material in this
article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the
material. If material is not included in the article’s Creative Commons licence and your intended use is not
permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from
the copyright holder. To view a copy of this licence, visit http://​creat​iveco​mmons.​org/​licen​ses/​by/4.​0/.

© The Author(s) 2023

Scientific Reports | (2023) 13:4912 | https://doi.org/10.1038/s41598-023-31749-8 7

Vol.:(0123456789)

You might also like